+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Company Analysis: Vertex

  • ID: 5357314
  • Company Profile
  • January 2021
  • 43 pages
  • Datamonitor Healthcare
The publisher explores Vertex’s prescription pharmaceutical performance and outlook over 2019-29.

Snapshot
  • Overview - Vertex is making impressive progress with its newly launched and late-stage investigational cystic fibrosis products.
  • Key themes - [1] Vertex is set for continued global cystic fibrosis market domination with its commercial and pipeline portfolios [2] Vertex’s cystic fibrosis franchise faces no short-to-medium-term competitive threats [3] Vertex is holding a hard line against ongoing pricing criticisms in the US and five major European markets.
Model updates (4 November 2020)
  • Trikafta forecast adjusted lower due to sales trends.
Model updates (31 July 2020)
  • Trikafta forecast adjusted higher due to continued robust launch in the US; EU and RoW forecasts adjusted higher due to assumed faster launch in those regions upon approval
  • Symdeko forecast adjusted lower in the US due to the cannibalization from Trikafta.
Model updates (29 April 2020)
  • Trikafta forecast adjusted significantly higher due to faster than expected uptake
  • Orkambi forecast adjusted lower due to accelerated pace of cannibalization from Trikafta
  • Symdeko forecast adjusted lower due to accelerated pace of cannibalization from Trikafta.
Model updates (30 January 2020)
  • Trikafta forecast adjusted higher due to stronger than expected launch
  • Orkambi forecast adjusted lower due to pace of cannibalization from Trikafta.
Note: Product cover images may vary from those shown
Company Background
  • Company Overview
  • Key Metrics
  • SWOT Analysis
  • Key Drug & Company Information
  • Company Comparison
Recent Earnings Review
  • Earnings Overview
Company Forecast
  • Prescription Pharmaceuticals Sales Outlook
  • Branded Drug Outlook
  • Therapy Area Outlook
  • Regional Sales Outlook
  • Lifecycle Analysis
Company Profile
  • Marketed & Pipeline Drugs
  • Recent Events & Analyst Opinions
  • Upcoming Catalysts
  • Recent Insights
Clinical Trial Overview
  • Clinical Trial Snapshot
  • Clinical Trials by Country
  • Clinical Trials by Status and Phase
  • Clinical Trials by Drug
Note: Product cover images may vary from those shown
Adroll
adroll